Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma

Cancer Biology and Therapy

Volumn 15, Issue 12, 2014, Pages 1613-1621

  Yuan, Li ^a   Liu, Zhi Hua ^a   Lin, Zhi Rui ^a   Xu, Li Hua ^a,b   Zhong, Qian ^a   Zeng, Mu Sheng ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

FGFR3 TACC3; Fusion gene; NPC; Proliferation; Tumorigenesis

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; FIBROBLAST GROWTH FACTOR RECEPTOR 3; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TRANSFORMING ACIDIC COILED COIL CONTAINING PROTEIN 3; UNCLASSIFIED DRUG; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; TACC3 PROTEIN, HUMAN;

ARTICLE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXON; FUSION GENE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; NASOPHARYNX CARCINOMA; SIGNAL TRANSDUCTION; CELL TRANSFORMATION; CHROMOSOME BREAKAGE; CHROMOSOME MAP; DNA SEQUENCE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; INTRON; MUTATION; NASOPHARYNX TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME BREAKPOINTS; CHROMOSOME MAPPING; EXONS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INTRONS; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; NASOPHARYNGEAL NEOPLASMS; ONCOGENE PROTEINS, FUSION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SEQUENCE ANALYSIS, DNA;

EID: 84920126464     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/15384047.2014.961874     Document Type: Article

References (30)

1. Chan ATC, Teo PML, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002; 13:1007-15; PMID:12176778; http://dx.doi.org/10.1093/annonc/mdf179
2. Dolly PH, Johnson PJ. Introduction: nasopharyngeal cancer. Semin Cancerbiol 2002; 12:419.
3. Kwok Wai L, Ka Fai T, Huang ADP. Focus on nasopharyngeal carcinoma. Cancer C 2004; 5:423-28; http://dx.doi.org/10.1016/S1535-6108(04)00119-9
4. Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, Chan K. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer 2010; 46:1967-78; PMID:20451372; http:// dx.doi.org/10.1016/j.ejca.2010.04.004
5. Tang LQ, ChenQY,Guo SS,ChenWH, Li CF,Zhang L, Lai XP, He Y, Xu YX, Hu DP, et al. The impact of plasma epstein-barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study. British J Cancer 2014; 111:1102-11; PMID:25051405; http://dx.doi. org/10.1038/bjc.2014.393
6. Sun D, Yang Z, Fu Y, Chen Y, Wang S, Zhang Y, Ma Y, Zhang X. Clinical value of serum Epstein-Barr virus DNA assay in the diagnosis of nasopharyngeal carcinoma. Tumour Biol: The J Int Soc Oncodev Biol Med 2014; PMID:24879626; http://dx.doi.org/10.1007/ s132770142148x
7. Lo KW, Chung GT, To KF. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol 2012; 22:79-86; PMID:22245473; http://dx.doi.org/ 10.1016/j.semcancer.2011.12.011
8. Lo K-W, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12:451-62; PMID:12450731; http://dx.doi.org/ 10.1016/S1044579X02000883
9. Xiao X, Zhao W, Tian F, Zhou X, Zhang J, Huang T, Hou B, Du C, Wang S, Mo Y, et al. Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma. Tumour Biol: The J Int Soc Oncodevel Biol Med 2014; 35:3755-63; PMID:24338690; http://dx.doi.org/10.1007/s13277-013-1497-1
10. Shu XS, Li L, Ji M, Cheng Y, Ying J, Fan Y, Zhong L, Liu X, Tsao SW, Chan AT, et al. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Carcinogenesis 2013; 34:1984-93; PMID:23677067; http://dx.doi.org/ 10.1093/carcin/bgt165
11. Lo K-W, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12:451-62; PMID:12450731; http://dx.doi.org/ 10.1016/S1044579X02000883
12. Grembecka J, He S, Shi A, Purohit T, Muntean AG, Sorenson RJ, Showalter HD, Murai MJ, Belcher AM, Hartley T, et al. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nat Chem Biol 2012; 8:277-84; PMID:22286128; http:// dx.doi.org/10.1038/nchembio.773
13. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007; 7:233-45; PMID:17361217; http://dx.doi.org/10.1038/nrc2091
14. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310:644-8; PMID:16254181; http://dx. doi.org/10.1126/science.1117679
15. Nam RK, Sugar L, Wang Z, YangW, Kitching R, Klotz LH, Venkateswaran V, Narod SA, Seth A. Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression. Cancer Biol Ther 2007; 6:40-5; PMID:17172822; http://dx.doi. org/10.4161/cbt.6.1.3489
16. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, et al. Identification of the transforming EML4-ALK fusion gene in non-smallcell lung cancer. Nature 2007; 448:561-6; PMID:17625570; http://dx.doi.org/10.1038/nature 05945
17. Chung GT, Lung RW, Hui AB, Yip KY, Woo JK, Chow C,TongCY, Lee SD, Yuen JW, Lun SW, et al. Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma. J Pathol 2013; 231:158-67; PMID:23878065; http://dx.doi.org/ 10.1002/path.4240
18. Nowell PC. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132:1497.
19. Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A, Liu EM, Reichel J, Porrati P, Pellegatta S, et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 2012; 337:1231-5; PMID:22837387; http://dx.doi.org/10.1126/science. 1220834
20. Brittany CP, Matti JA, David EC, Kirsi JG, Yan S, Ping J, Xia L, Joy G, Hong Z, Limei H, et al. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J Clin Invest 2013; 123:855-65; PMID:23298836
21. Wu YM, Su F, Kalyana-Sundaram S, Khazanov N, Ateeq B, Cao X, Lonigro RJ, Vats P, Wang R, Lin SF, et al. Identification of targetable FGFR gene fusions in diverse cancers. Cancer Disc 2013; 3:636-47; PMID:23558953; http://dx.doi.org/10.1158/2159-8290.CD-13-0050
22. Majewski IJ, Mittempergher L, Davidson NM, Bosma A, Willems SM, Horlings HM, de Rink I, Greger L, Hooijer GK, Peters D, et al. Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing. J Pathol 2013; 230:270-6; PMID:23661334; http:// dx.doi.org/10.1002/path.4209
23. Falini B, Mason DY. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. Blood 2002; 99:409-26; PMID:11781220; http://dx.doi.org/10.1182/blood. V99.2.409
24. Kas K, Voz ML, Roijer E, Astrom AK, Meyen E, Stenman G, Van de Ven WJ. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet 1997; 15:170-4; PMID: 9020842; http://dx.doi.org/10.1038/ng0297-170
25. Williams SV, Hurst CD, Knowles MA. Oncogenic FGFR3 gene fusions in bladder cancer. Human Mol Genet 2013; 22:795-803; PMID:23175443; http://dx. doi.org/10.1093/hmg/dds486
26. Annala MJ, Parker BC, Zhang W, Nykter M. Fusion genes and their discovery using high throughput sequencing. Cancer Lett 2013; 340:192-200; PMID: 23376639; http://dx.doi.org/10.1016/j.canlet.2013. 01.011
27. Bellus GA, McIntosh I, Smith EA, Aylsworth AS, Kaitila I, Horton WA, Greenhaw GA, Hecht JT, Francomano CA. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet 1995; 10:357-9; PMID:7670477; http://dx.doi.org/ 10.1038/ng0795-357
28. Iyer G, Milowsky MI. Fibroblast growth factor receptor-3 in urothelial tumorigenesis. Urol Oncol 2013; 31:303-11; PMID:22285006; http://dx.doi. org/10.1016/j.urolonc.2011.12.001
29. Pandith AA, Shah ZA, Siddiqi MA. Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer. Urol Oncol 2013; 31:398-406; PMID:20822928; http://dx.doi.org/10.1016/j.urolonc. 2010.07.014
30. Yen YC, Shiah SG, Chu HC, Hsu YM, Hsiao JR, Chang JY, Hung WC, Liao CT, Cheng AJ, Lu YC, et al. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Mol Cancer 2014; 13:6; PMID:24410957; http://dx.doi.org/10.1186/1476-4598-13-6